Akero Therapeutics, Inc.
AKRO:NasdaqGS
7.407%
(Fri, 01 Jul 2022 20:00:04 +0000)
Nasdaq Real Time Price
Realtime signal
SELL
BUY
| Long Term Signal | SELL |
|---|---|
| Pivot R2 | 9.88 |
| Pivot R1 | 9.67 |
| Last | 10.15 |
| Pivot S1 | 9.25 |
| Pivot S2 | 9.04 |
| Week52high | 26.98 |
|---|---|
| Week52low | 7.52 |
| Day50MovingAvg | 9.6244 |
| Day200MovingAvg | 17.10195 |
| Beta (5Y Monthly) | 0.78 |
| PE Ratio (TTM) | 0.00 |
| EPS (TTM) | -3.202 |
| Earnings Date | Aug 11 - Aug 15 |
Recommendation Trend
| Jul | Jun | May | Apr | |
| Strong Buy | 0 | 2 | 2 | 0 |
| Buy | 0 | 3 | 3 | 0 |
| Hold | 0 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 0 | 6 | 6 | 0 |
Upgrade Downgrade History
| Morgan Stanley Nov 15 Maintains |
to Equal-Weight |
|---|---|
| HC Wainwright & Co. Nov 15 Maintains |
to Buy |
| Morgan Stanley Oct 19 Downgrade |
Overweight to Equal-Weight |
| B of A Securities Sep 10 Initiated |
to Buy |
| HC Wainwright & Co. Aug 16 Maintains |
to Buy |
| Morgan Stanley Mar 23 Maintains |
to Overweight |
| HC Wainwright & Co. Mar 23 Maintains |
to Buy |
| Canaccord Genuity Mar 18 Maintains |
to Buy |
| Chardan Capital Mar 17 Maintains |
to Buy |
| HC Wainwright & Co. Mar 17 Maintains |
to Buy |